文献速递外周动脉疾病血液透析通路

经桡动脉与经股动脉入路在外周动脉疾病血管成形与支架术中的比较:比较性研究的荟萃分析与系统评价

Transradial Access Versus Transfemoral Access in Angioplasty and Stenting for Peripheral Arterial Diseases: A Meta-Analysis of Comparative Studies and Systematic Review.
PubMed 文献 · J Endovasc Ther · 2026-08-13

结果显示两组技术成功率无显著差异,但经桡动脉入路与更短住院时间相关,并显著降低大出血风险,入路部位并发症有减少趋势。经桡动脉入路可能成为尤其当股动脉入路不可行时的优选方案。

要点

  • 经桡动脉与经股动脉入路的技术成功率无显著差异。
  • 经桡动脉入路住院时间更短,大出血风险显著降低。
  • 下肢介入中经桡动脉入路入路部位并发症显著减少。

核心结论

  • 经桡动脉入路行外周血管成形和支架术在缩短住院时间、减少入路部位并发症和降低出血风险方面优于经股动脉入路。
  • 随着经桡动脉技术进展,经桡动脉可能成为首选入路,尤其当经股动脉入路不可行时。

研究设计与样本

  • 遵循PRISMA指南的系统评价与荟萃分析,纳入比较经桡动脉与经股动脉入路在外周动脉疾病患者中应用的随机对照试验和队列研究。
  • 使用Cochrane工具评估偏倚风险,采用RevMan 5.3进行统计分析。

主要发现

  • 技术成功率无显著差异(OR=1.48,P=.36,95%CI 0.64~3.54)。
  • 经桡动脉入路与更短住院时间相关(均数差=-0.09天,P=.01,95%CI -0.16~-0.02)。
  • 入路部位并发症有减少趋势(OR=0.49,P=.07,95%CI 0.23~1.06),下肢介入中显著减少(P<.01)。
  • 轻微出血有减少趋势(P=.09),大出血显著减少(P=.03)。

临床怎么用

  • 经桡动脉入路可作为外周动脉介入的实用替代方案,尤其当经股动脉入路不可行时。
  • 经桡动脉入路有助于缩短住院时间和降低出血风险,对患者康复和医疗资源利用均有获益。
  • 在某些股腘动脉介入中经股动脉入路仍更可取,经桡动脉专用器械和机器人技术的普及可能进一步拓展经桡动脉入路的应用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To compare the efficacy and safety of transradial (TR) versus transfemoral (TF) access in peripheral arterial angioplasty and stenting, providing evidence to guide clinical decision-making in endovascular interventions. METHODS: A systematic review and meta-analysis were conducted following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Randomized controlled trials (RCTs) and cohort studies comparing TR and TF approaches in patients with peripheral artery disease (PAD) were included. Databases (PubMed, Embase, and Cochrane Library) were searched up to May 10, 2025. Risk of bias was assessed using the Cochrane tool, and RevMan 5.3 was used for statistical analysis. Outcomes included technical success, fluoroscopy time, hospital stay, minor/major bleeding, and access site complications. RESULTS: Seventeen studies (13 210 patients) were analyzed. No significant difference was found in technical success (odds ratio [OR] = 1.48, P = .36, 95% CI, 0.64, 3.54). However, TR access was associated with a shorter hospital stay (mean difference = -0.09 days, P = .01, 95% CI, -0.16, -0.02) and a trend toward fewer access site complications (OR = 0.49, P = .07, 95% CI, 0.23, 1.06), with significant reduction in lower extremity interventions (P < .01). Transradial also showed lower bleeding risks, with a trend in minor bleeding (P = .09) and significant reduction in major bleeding (P = .03). CONCLUSION: Transradial access for peripheral angioplasty and stenting offers advantages over TF, including reduced hospital stay, fewer complications, and lower bleeding risks. As TR techniques advance, TR may become the preferred approach, particularly when TF access is not feasible.Clinical ImpactThis study provides clinically relevant evidence supporting transradial (TR) access as a practical alternative to transfemoral (TF) access for peripheral arterial interventions. TR access showed fewer access-site complications, shorter hospitalization, and a trend toward reduced bleeding, suggesting benefits for both patient recovery and healthcare resource use. Although TF access remains preferable in certain femoropopliteal interventions, the growing availability of TR-specific devices and robotic technologies may further expand the role of TR access. These findings can guide access-site selection and improve procedural safety in clinical practice.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Yang W, Peng Z, Pu H, et al. Transradial Access Versus Transfemoral Access in Angioplasty and Stenting for Peripheral Arterial Diseases: A Meta-Analysis of Comparative Studies and Systematic Review. J Endovasc Ther. 2026. PMID: 42590943. doi:10.1177/15266028261477039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。